A nomogram integrating TO, lymph node metastasis, prothrombin time, and adjuvant therapy demonstrated excellent predictive accuracy for survival (1-year area under the curve = 0.891).<h4>Conclusion</h4>Achieving TO is associated with significantly improved survival in patients with ICC. This evidence concerns the gene F2 and metastatic malignant neoplasm in the lymph nodes.